Preoperative prediction of glypican-3 positive expression in solitary hepatocellular carcinoma on gadoxetate-disodium enhanced magnetic resonance imaging.

Front Immunol · 2022 · PMC9453305 · PMID 36091074

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Despite no significant difference in RFS or OS detected between patients with pathologically or model-predicted confirmed GPC-3 expression, Kaplan–Meier survival curves still showed a trend wise longer survival in patients with GPC-3-negative HCC.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.